Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study

Authors: Luis Coentrão, Carla Santos-Araújo, Claudia Dias, Ricardo Neto, Manuel Pestana

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

Although several studies have demonstrated early survival advantages with peritoneal dialysis (PD) over hemodialysis (HD), the reason for the excess mortality observed among incident HD patients remains to be established, to our knowledge. This study explores the relationship between mortality and dialysis modality, focusing on the role of HD vascular access type at the time of dialysis initiation.

Methods

A retrospective cohort study was performed among local adult chronic kidney disease patients who consecutively initiated PD and HD with a tunneled cuffed venous catheter (HD-TCC) or a functional arteriovenous fistula (HD-AVF) in our institution in the year 2008. A total of 152 patients were included in the final analysis (HD-AVF, n = 59; HD-TCC, n = 51; PD, n = 42). All cause and dialysis access-related morbidity/mortality were evaluated at one year. Univariate and multivariate analysis were used to compare the survival of PD patients with those who initiated HD with an AVF or with a TCC.

Results

Compared with PD patients, both HD-AVF and HD-TCC patients were more likely to be older (p<0.001) and to have a higher frequency of diabetes mellitus (p = 0.017) and cardiovascular disease (p = 0.020). Overall, HD-TCC patients were more likely to have clinical visits (p = 0.069), emergency room visits (p<0.001) and hospital admissions (p<0.001). At the end of follow-up, HD-TCC patients had a higher rate of dialysis access-related complications (1.53 vs. 0.93 vs. 0.64, per patient-year; p<0.001) and hospitalizations (0.47 vs. 0.07 vs. 0.14, per patient-year; p = 0.034) than HD-AVF and PD patients, respectively. The survival rates at one year were 96.6%, 74.5% and 97.6% for HD-AVF, HD-TCC and PD groups, respectively (p<0.001). In multivariate analysis, HD-TCC use at the time of dialysis initiation was the important factor associated with death (HR 16.128, 95%CI [1.431-181.778], p = 0.024).

Conclusion

Our results suggest that HD vascular access type at the time of renal replacement therapy initiation is an important modifier of the relationship between dialysis modality and survival among incident dialysis patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lameire N, Wauters JP, Górriz JL, et al: An update on the referral pattern of patients with end-stage renal disease. Kidney Int. 2002, 61: S27-S34. 10.1046/j.1523-1755.61.s80.6.x.CrossRef Lameire N, Wauters JP, Górriz JL, et al: An update on the referral pattern of patients with end-stage renal disease. Kidney Int. 2002, 61: S27-S34. 10.1046/j.1523-1755.61.s80.6.x.CrossRef
2.
go back to reference Górriz J, Sancho A, Pallardó LM, et al: Significado prognóstico de la diálisis programada en pacientes que inician tratamiento substituivo renal. Un estúdio multicéntrico español. Nefrologia. 2001, 21: 49-59. Górriz J, Sancho A, Pallardó LM, et al: Significado prognóstico de la diálisis programada en pacientes que inician tratamiento substituivo renal. Un estúdio multicéntrico español. Nefrologia. 2001, 21: 49-59.
3.
go back to reference Buck J, Baker R, Cannaby AM, et al: Why do patients known to renal services still undergo urgent dialysis initiation? A cross-sectional survey. Nephrol Dial Transplant. 2007, 22 (11): 3240-3245. 10.1093/ndt/gfm387.CrossRefPubMed Buck J, Baker R, Cannaby AM, et al: Why do patients known to renal services still undergo urgent dialysis initiation? A cross-sectional survey. Nephrol Dial Transplant. 2007, 22 (11): 3240-3245. 10.1093/ndt/gfm387.CrossRefPubMed
4.
go back to reference Mendelssohn DC, Malmbrg C, Hamandi B: An integrated review of “unplanned” dialysis initiation: reframing the terminology to “suboptimal” initiation. BMC Nephrol. 2009, 10: 22-10.1186/1471-2369-10-22.CrossRefPubMedPubMedCentral Mendelssohn DC, Malmbrg C, Hamandi B: An integrated review of “unplanned” dialysis initiation: reframing the terminology to “suboptimal” initiation. BMC Nephrol. 2009, 10: 22-10.1186/1471-2369-10-22.CrossRefPubMedPubMedCentral
5.
go back to reference Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010, 21: 499-506. 10.1681/ASN.2009060635.CrossRefPubMedPubMedCentral Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010, 21: 499-506. 10.1681/ASN.2009060635.CrossRefPubMedPubMedCentral
6.
go back to reference Heaf JG, Lokkegaard H, Madsen M: Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant. 2002, 17: 112-117.CrossRefPubMed Heaf JG, Lokkegaard H, Madsen M: Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant. 2002, 17: 112-117.CrossRefPubMed
7.
go back to reference Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT: Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int. 2003, 64: 2222-2228. 10.1046/j.1523-1755.2003.00321.x.CrossRefPubMed Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, Krediet RT: Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int. 2003, 64: 2222-2228. 10.1046/j.1523-1755.2003.00321.x.CrossRefPubMed
8.
go back to reference Manns B, Tonelli M, Yilmaz S, et al: Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol. 2005, 16: 201-209.CrossRefPubMed Manns B, Tonelli M, Yilmaz S, et al: Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol. 2005, 16: 201-209.CrossRefPubMed
9.
go back to reference Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: Data from the Canadian Organ Replacement Registry 2001–2004. Clin J Am Soc Nephrol. 2008, 3: 1726-1732. 10.2215/CJN.01240308.CrossRefPubMedPubMedCentral Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: Data from the Canadian Organ Replacement Registry 2001–2004. Clin J Am Soc Nephrol. 2008, 3: 1726-1732. 10.2215/CJN.01240308.CrossRefPubMedPubMedCentral
10.
go back to reference de Jager DJ, Grootendorst DC, Jager KJ, et al: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009, 302 (16): 1782-1789. 10.1001/jama.2009.1488.CrossRefPubMed de Jager DJ, Grootendorst DC, Jager KJ, et al: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009, 302 (16): 1782-1789. 10.1001/jama.2009.1488.CrossRefPubMed
11.
go back to reference Astor BC, Eustace JZ, Powe NR, the CHOICE Study, et al: Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005, 16: 1449-1455. 10.1681/ASN.2004090748.CrossRefPubMed Astor BC, Eustace JZ, Powe NR, the CHOICE Study, et al: Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005, 16: 1449-1455. 10.1681/ASN.2004090748.CrossRefPubMed
12.
go back to reference Rehman R, Schmidt RJ, Moss AH: Ethical and Legal Obligation to Avoid Long-Term Tunneled Catheter Access. Clin J Am Soc Nephrol. 2009, 4: 456-460. 10.2215/CJN.03840808.CrossRefPubMed Rehman R, Schmidt RJ, Moss AH: Ethical and Legal Obligation to Avoid Long-Term Tunneled Catheter Access. Clin J Am Soc Nephrol. 2009, 4: 456-460. 10.2215/CJN.03840808.CrossRefPubMed
13.
go back to reference Aslam N, Bernardini J, Fried L, et al: Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol. 2006, 1: 1226-1233. 10.2215/CJN.01230406.CrossRefPubMed Aslam N, Bernardini J, Fried L, et al: Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol. 2006, 1: 1226-1233. 10.2215/CJN.01230406.CrossRefPubMed
14.
go back to reference Rodrigues A: How to persuade peritoneal dialysis-skeptical hemodialysis fans. Contrib Nephrol. 2009, 163: 237-242.CrossRefPubMed Rodrigues A: How to persuade peritoneal dialysis-skeptical hemodialysis fans. Contrib Nephrol. 2009, 163: 237-242.CrossRefPubMed
15.
go back to reference Perl J, Wald R, McFarlane P, et al: Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol. 2011, 22: 1113-1121. 10.1681/ASN.2010111155.CrossRefPubMedPubMedCentral Perl J, Wald R, McFarlane P, et al: Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol. 2011, 22: 1113-1121. 10.1681/ASN.2010111155.CrossRefPubMedPubMedCentral
16.
go back to reference Raithatha A, McKane W, Kendray D, Evans C: Catheter access for hemodialysis defines higher mortality in late-presenting dialysis patients. Ren Fail. 2010, 32 (10): 1183-1188. 10.3109/0886022X.2010.517347.CrossRefPubMed Raithatha A, McKane W, Kendray D, Evans C: Catheter access for hemodialysis defines higher mortality in late-presenting dialysis patients. Ren Fail. 2010, 32 (10): 1183-1188. 10.3109/0886022X.2010.517347.CrossRefPubMed
18.
go back to reference Charlson ME, Pompei P, Ales KL: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Am Soc Nephrol. 1996, 7: 198-207. Charlson ME, Pompei P, Ales KL: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Am Soc Nephrol. 1996, 7: 198-207.
19.
go back to reference Allon M, Work J: Venous catheter access for hemodialysis. Handbook of dialysis. Edited by: Daugirdas J, Blake P, Ing T. 2007, Philadelphia, USA: Lippincott Williams & Wilkins, 87-104. Allon M, Work J: Venous catheter access for hemodialysis. Handbook of dialysis. Edited by: Daugirdas J, Blake P, Ing T. 2007, Philadelphia, USA: Lippincott Williams & Wilkins, 87-104.
20.
go back to reference Campos RP, Chula DC, Riella MC: Complications of the peritoneal access and their management. Contrib Nephrol. 2009, 163: 183-197.CrossRefPubMed Campos RP, Chula DC, Riella MC: Complications of the peritoneal access and their management. Contrib Nephrol. 2009, 163: 183-197.CrossRefPubMed
21.
go back to reference Quinn RR, Hux JE, Oliver MJ, et al: Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol. 2011, 22: 1534-1542. 10.1681/ASN.2010121232.CrossRefPubMedPubMedCentral Quinn RR, Hux JE, Oliver MJ, et al: Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol. 2011, 22: 1534-1542. 10.1681/ASN.2010121232.CrossRefPubMedPubMedCentral
22.
go back to reference Covic A, Bammens B, Lobbedez T, et al: Educating end-stage renal disease patients on dialysis modality selection: a clinical advice from the European Renal Best Practice (ERBP) Advisory Board. NDT Plus. 2010, 3: 225-233. 10.1093/ndtplus/sfq059. Covic A, Bammens B, Lobbedez T, et al: Educating end-stage renal disease patients on dialysis modality selection: a clinical advice from the European Renal Best Practice (ERBP) Advisory Board. NDT Plus. 2010, 3: 225-233. 10.1093/ndtplus/sfq059.
23.
go back to reference Oliver MJ, Rothwell DM, Fung K, et al: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol. 2004, 15: 1936-1942. 10.1097/01.ASN.0000131524.52012.F8.CrossRefPubMed Oliver MJ, Rothwell DM, Fung K, et al: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol. 2004, 15: 1936-1942. 10.1097/01.ASN.0000131524.52012.F8.CrossRefPubMed
24.
go back to reference Oliver MJ, Verrelli M, Zacharias JM, Blake PG, Garg AX, Johnson JF, Pandeya S, Perl J, Kiss AJ, Quinn RR: Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrol Dial Transplant Jun. 2011, 2: [Epub ahead of print] Oliver MJ, Verrelli M, Zacharias JM, Blake PG, Garg AX, Johnson JF, Pandeya S, Perl J, Kiss AJ, Quinn RR: Choosing peritoneal dialysis reduces the risk of invasive access interventions. Nephrol Dial Transplant Jun. 2011, 2: [Epub ahead of print]
25.
go back to reference Povlsen JV, Ivarsen P: How to start the late referred ESRD patient urgently on chronic APD. Nephrol Dial Transplant. 2006, 21 (Suppl 2): ii56-ii59.PubMed Povlsen JV, Ivarsen P: How to start the late referred ESRD patient urgently on chronic APD. Nephrol Dial Transplant. 2006, 21 (Suppl 2): ii56-ii59.PubMed
26.
Metadata
Title
Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study
Authors
Luis Coentrão
Carla Santos-Araújo
Claudia Dias
Ricardo Neto
Manuel Pestana
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-88

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine